Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTF2I repeat domain containing 2 pseudogene 1 (GTF2IRD2P1) is a pseudogene within the GTF2I repeat domain protein family, mapped to human chromosome 7q11.23, in the region associated with Williams-Beuren syndrome. Pseudogenes such as GTF2IRD2P1 typically arise from duplication or retrotransposition events and do not encode a functional protein. There is no evidence for transcription or functional activity, and it is not considered a therapeutic target. The related functional gene, GTF2IRD2, encodes a protein with potential transcription regulatory roles, but GTF2IRD2P1 lacks such activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTF2I repeat domain containing 2 pseudogene 1 (GTF2IRD2P1).